Ventaira Pharmaceuticals Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Ventaira Pharmaceuticals General Information

Description

Developer of pharmaceutical products for inhalation. The company develops inhaled drugs including fentanyl for the treatment of breakthrough pain and salmeterol for asthma. It focuses on the development of new inhalation products by utilizing its novel proprietary electrohydrodynamic aerosolization.

Contact Information

Website
www.ventaira.com
Formerly Known As
BattellePharma
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1801 Watermark Drive
  • Suite 100
  • Columbus, OH 43215
  • United States
+1 (614)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Battelle
Vertical(s)
Life Sciences
Corporate Office
  • 1801 Watermark Drive
  • Suite 100
  • Columbus, OH 43215
  • United States
+1 (614)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ventaira Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 30-Oct-2007 Completed Generating Revenue
3. Later Stage VC 12-Jun-2007 Completed Generating Revenue
2. Later Stage VC (Series C) 19-Oct-2005 $13.5M $38.5M Completed Generating Revenue
1. Later Stage VC (Series B) 27-Feb-2003 $25M $25M Completed Generating Revenue
To view Ventaira Pharmaceuticals’s complete valuation and funding history, request access »

Ventaira Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B1
Series B
Class 2 Series A
Class 1 Series A 302,956 $0.010000 8% $1.74 $1.74 $1.74 0.89%
Series A 685,803 $0.010000 8% $1.74 $1.74 $1.74 2.01%
To view Ventaira Pharmaceuticals’s complete cap table history, request access »

Ventaira Pharmaceuticals Patents

  • 47

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Ventaira Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-118323-S Drug dispenser Inactive 24-May-2006
US-20050118108-A1 Active agent combined with liquid carrier comprised of liquid fluorocarbon, cosolvent, phospholipid and excipients; electrohydrodynamic aerosol spraying Inactive 28-Nov-2003
JP-2006521174-A Improved nozzle for aerosol delivery device for handheld lung disease Pending 28-Feb-2003
AU-2003248728-A1 Piezoelectric micropump with diaphragm and valves Inactive 01-Jul-2002
AU-2003280107-A1 Drug containment system Inactive 01-Jul-2002 A61J1/1406
To view Ventaira Pharmaceuticals’s complete patent history, request access »

Ventaira Pharmaceuticals Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Battelle Ventures Venture Capital Minority
Early Stage Partners Venture Capital Minority
Fletcher Spaght Ventures Venture Capital Minority
James Richardson and Sons Merchant Banking Firm Minority
Merlin BioMed Group Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial

Ventaira Pharmaceuticals FAQs

  • When was Ventaira Pharmaceuticals founded?

    Ventaira Pharmaceuticals was founded in 1997.

  • Where is Ventaira Pharmaceuticals headquartered?

    Ventaira Pharmaceuticals is headquartered in Columbus, OH.

  • What industry is Ventaira Pharmaceuticals in?

    Ventaira Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Ventaira Pharmaceuticals a private or public company?

    Ventaira Pharmaceuticals is a Private company.

  • What is Ventaira Pharmaceuticals’s current revenue?

    The current revenue for Ventaira Pharmaceuticals is .

  • How much funding has Ventaira Pharmaceuticals raised over time?

    Ventaira Pharmaceuticals has raised $39.5M.

  • Who are Ventaira Pharmaceuticals’s investors?

    Battelle Ventures, Early Stage Partners, Fletcher Spaght Ventures, James Richardson and Sons, and Merlin BioMed Group are 5 of 11 investors who have invested in Ventaira Pharmaceuticals.

  • When was Ventaira Pharmaceuticals acquired?

    Ventaira Pharmaceuticals was acquired on 30-Oct-2007.

  • Who acquired Ventaira Pharmaceuticals?

    Ventaira Pharmaceuticals was acquired by Battelle.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »